Inhibition of protein misfolding and aggregation by natural phenolic compounds

Cellular and Molecular Life Sciences : CMLS
Zohra DhouafliInes Moreno-Gonzalez

Abstract

Protein misfolding and aggregation into fibrillar deposits is a common feature of a large group of degenerative diseases affecting the central nervous system or peripheral organs, termed protein misfolding disorders (PMDs). Despite their established toxic nature, clinical trials aiming to reduce misfolded aggregates have been unsuccessful in treating or curing PMDs. An interesting possibility for disease intervention is the regular intake of natural food or herbal extracts, which contain active molecules that inhibit aggregation or induce the disassembly of misfolded aggregates. Among natural compounds, phenolic molecules are of particular interest, since most have dual activity as amyloid aggregation inhibitors and antioxidants. In this article, we review many phenolic natural compounds which have been reported in diverse model systems to have the potential to delay or prevent the development of various PMDs, including Alzheimer's and Parkinson's diseases, prion diseases, amyotrophic lateral sclerosis, systemic amyloidosis, and type 2 diabetes. The lower toxicity of natural compounds compared to synthetic chemical molecules suggest that they could serve as a good starting point to discover protein misfolding inhibitors that mi...Continue Reading

References

Nov 15, 1990·Biochemical and Biophysical Research Communications·J M HerbertJ P Maffrand
Feb 1, 1996·Current Opinion in Structural Biology·J W Kelly
Sep 2, 1999·Trends in Biochemical Sciences·C M Dobson
Mar 31, 2000·Nature Structural Biology·T KlabundeJ C Sacchettini
Jan 4, 2003·Nature Reviews. Neuroscience·Claudio Soto
Feb 13, 2003·Journal of Neuroscience Methods·Fang BaChristina G Benishin
Mar 5, 2003·Cellular and Molecular Life Sciences : CMLS·C Hetz, C Soto
Apr 15, 2003·Journal of Virology·Byron CaugheyGerald S Baron
Mar 3, 2004·Journal of Neuroscience Research·Kenjiro OnoMasahito Yamada
May 13, 2004·Journal of Agricultural and Food Chemistry·Daniele Del RioAlan Crozier
Jun 3, 2004·Lancet·Ali SamiiBruce R Ransom
Dec 14, 2004·The Journal of Biological Chemistry·Fusheng YangGregory M Cole
Dec 22, 2004·The Journal of Biological Chemistry·Sayuri TaniguchiMasato Hasegawa
Mar 29, 2005·Nature Genetics·J Alex ParkerChristian Néri
Jun 10, 2005·Nature·Rebecca NelsonDavid Eisenberg
Sep 16, 2005·The Journal of Biological Chemistry·Philippe MarambaudPeter Davies
Oct 27, 2005·Journal of Agricultural and Food Chemistry·Hee KimSung-Eun Lee
Feb 14, 2006·Trends in Biochemical Sciences·Claudio SotoJoaquín Castilla
Feb 24, 2006·The Journal of Pharmacology and Experimental Therapeutics·Teresa IuvoneAngelo A Izzo
Jul 18, 2006·Current Pharmaceutical Design·L D Estrada, C Soto
Oct 31, 2006·Biochimica Et Biophysica Acta·Katsumi MatsuzakiHironobu Naiki
Aug 2, 2007·EMBO Reports·Elodie Monsellier, Fabrizio Chiti
Jan 15, 2008·Acta Neuropathologica·Neeraj PandeyJames E Galvin
May 31, 2008·Nature Structural & Molecular Biology·Dagmar E EhrnhoeferErich E Wanker
Dec 2, 2008·Neurochemistry International·Saravanan S KaruppagounderGary E Gibson
Jan 24, 2009·Chembiochem : a European Journal of Chemical Biology·Rajesh MishraRoland Winter
Apr 22, 2009·Acta Neuropathologica·Charles DuyckaertsMarie-Claude Potier
May 9, 2009·PLoS Pathogens·Zrinka MarijanovicChiara Zurzolo
Jun 25, 2009·Journal of Neurochemistry·Wenkai LiVirginia M-Y Lee
Jul 21, 2009·The Journal of Nutritional Biochemistry·Stefania RigacciAndrea Berti
Nov 7, 2009·The American Journal of Pathology·Tsuyoshi HamaguchiMasahito Yamada

❮ Previous
Next ❯

Citations

May 30, 2019·Biology·Andrei SurguchovAlexei A Surguchev
May 24, 2020·International Journal of Molecular Sciences·Hatasu KobayashiShinji Oikawa
Apr 9, 2020·Frontiers in Molecular Neuroscience·Ana F RaimundoRegina Menezes
Jul 12, 2020·Journal of Alzheimer's Disease : JAD·Camila CalfioRicardo B Maccioni
Oct 24, 2019·Translational Psychiatry·Jee Wook KimUNKNOWN KBASE Research Group
Jul 12, 2019·Frontiers in Aging Neuroscience·George A Edwards IiiInes Moreno-Gonzalez
Aug 23, 2019·Critical Reviews in Toxicology·Tian YangYing-Yong Zhao
Apr 10, 2020·Journal of Computer-aided Molecular Design·Bani Kumar PathakJayati Sengupta
Feb 7, 2019·Frontiers in Neuroscience·Karina JoppePaul Lingor
Dec 31, 2020·Critical Reviews in Food Science and Nutrition·Zongxin LingShaochang Wu
Nov 29, 2020·Antiviral Research·Valeria BariliPaola Fisicaro
Nov 1, 2020·International Journal of Biological Macromolecules·Jufei XuWeihong Du
Jan 19, 2021·International Journal of Biological Macromolecules·Chunjun Yan, Zheng Zhou
Sep 16, 2019·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Marta Gallardo-FernándezM Carmen García-Parrilla
Oct 15, 2020·Acta neurologica Belgica·Gabriele CiprianiSabrina Danti
May 11, 2021·International Journal of Biological Macromolecules·Lei ZhangMojtaba Falahati
May 29, 2021·Protein Science : a Publication of the Protein Society·Masatomo SoYuji Goto
May 23, 2020·ACS Chemical Neuroscience·Chendi ZhanGuanghong Wei

❮ Previous
Next ❯

Methods Mentioned

BETA
protein folding
transgenic

Related Concepts

Related Feeds

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

© 2022 Meta ULC. All rights reserved